A Multiple Regression-Based Method for NIPT Timing Selection and Fetal Abnormality Detection
DOI:
https://doi.org/10.54097/h3s8a016Keywords:
Non-Invasive Prenatal Testing, Interaction Regression, Gradient Boosting Decision Trees, Random Forest, Logistic Regression.Abstract
Non-invasive prenatal testing (NIPT) is a widely applied clinical technique for detecting fetal chromosomal abnormalities by analyzing cell-free fetal DNA fragments in maternal plasma. The accuracy and reliability of NIPT are affected by multiple factors, including gestational age and maternal body mass index (BMI). This paper investigates the correlation between Y chromosome concentration, gestational weeks, and BMI in male fetuses, as well as the feasibility of predicting female fetal abnormalities in the absence of Y chromosome signals. To address these issues, this article establish a comprehensive framework combining interaction regression analysis, gradient boosting decision trees (GBDT), rule-based grouping, random forests, and logistic regression models. Based on historical data, optimal NIPT time points are estimated for different BMI groups by calculating the gestational weeks at which 95% of pregnant[1] women achieve the required fetal DNA concentration, with additional safety margins introduced to enhance robustness. Experimental results show that the optimal testing window for male fetuses is approximately 11 ± 3 weeks, while the proposed model achieves a precision of 0.8178 and a recall of 0.8621 for female fetal abnormality detection. The findings provide practical clinical recommendations to minimize potential testing risks, improve detection success rates across maternal BMI groups, and offer effective judgment methods for female fetuses lacking Y chromosome markers.
References
[1] Shi Weihui, Xu Chenming. The Application Value of Non-invasive Prenatal Testing in the Diagnosis of Maternal Complications and Comorbidities in Obstetrics [J]. Practical Journal of Obstetrics and Gynecology, 2025, 41 (08): 617-620.
[2] Jiang Liya, Lu Shaokai, Du Jiayin, et al. Development and Application of Non-invasive Prenatal Testing Technology [J]. Clinical Medical Research and Practice, 2025, 10 (23): 191-194.
[3] Yu Dandan, Li Fengjin, Yao Xinyu, et al. Efficacy Analysis of NIPT in Detecting Common Chromosomal Aneuploidies in Fetuses of Different High-Risk Groups [J]. China Family Planning and Obstetrics and Gynecology, 2025, 17 (03): 72-76+82.
[4] Qian Yue, Jin Kerqin, Hu Min, et al. Screening Value of Expanded Non-invasive Prenatal Testing for Pregnant Women at High Risk of Down Syndrome [J]. Zhejiang Clinical Medicine, 2025, 27 (02): 180-183.
[5] Li Na, Li Yipei, Yang Weixian, et al. Analysis of the Application Value of Non-invasive Prenatal Testing Technology in the Diagnosis of Fetal Sex Chromosome Aneuploidies [J]. China Maternal and Child Health Care, 2024, 39 (24): 4963-4966.
[6] Li Shanshan, Zhang Meng, Lv Wei, et al. Prenatal Diagnosis and Genetic Analysis of NIPT Cases with Chromosome 9 Abnormalities [J]. Journal of Clinical Laboratory Medicine, 2024, 21 (22): 3380-3387. DOI: CNKI: SUN: JYYL.0.2024-22-023.
[7] Wu Jianfang, Liang Lisheng, Zheng Zhi, et al. Analysis of the Results of Non-invasive Prenatal Testing for Trisomy 21 Screening Based on Single Indicator MOM Value [J]. China Prenatal Diagnosis Journal (Electronic Edition), 2024, 16 (03): 30-35.
[8] Pan Shuqing, Pan Xiaoli, Ge Lizha, et al. The Application Value of Non-invasive Prenatal Testing in Prenatal Screening [J]. Zhejiang Medicine, 2024, 46 (17): 1881-1884.
[9] Li Jingjing, DAVID Lubasi Nalisa, Sun Zongli. Study on the Current Status of Non-invasive DNA Prenatal Testing among Pregnant Women in a Certain Area of Henan Province from 2021 to 2022 [J]. Modern Disease Prevention and Control, 2024, 35 (08): 613-616+625.
[10] Zhang Hongyun. Research on the Development and Applicability Evaluation of Non-invasive Prenatal Screening Technology for 66 Dominant Single Gene Diseases [D]. Central South University, 2023.
[11] Yuan Xiying. Clinical Application Study on Fetal Chromosome Aneuploidies Screening and Prenatal Diagnosis in Twin Pregnancy with Non-invasive Prenatal Testing [D]. Central South University, 2023.
[12] Cheng Yan, Ma Wen, Quan Qiuning, et al. The Application Value of DNA Non-invasive Prenatal Testing and Color Doppler Ultrasound Examination in the Screening of Fetal Chromosome Abnormalities in High-Risk Pregnant Women [J]. Journal of Clinical Laboratory Medicine, 2024, 21(02):217-220.
[13] Wang Yalin. Non-invasive prenatal testing: Towards the next decade [J]. Clinical Pediatrics Journal, 2024, 42(01):15-19.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







